2021
DOI: 10.1097/ju.0000000000002015.05
|View full text |Cite
|
Sign up to set email alerts
|

Mp24-05 long-Term Follow-Up and Prognostic Factor Analysis in Men With Metastatic Castration-Resistant Prostate Cancer (Mcrpc) Who Receive Prostate-Specific Membrane Antigen (Psma)-Targeted Lutetium-177 (177lu)

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles